BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ATP2B3, PMCA3, 492, ENSG00000067842 AND Treatment
53 results:

  • 1. Effect of comprehensive nursing care for the liver cancer patients undergoing interventional therapy in China: A systematic review and meta-analysis.
    Zhang S; Li N; Mao X; Yang D
    Int J Nurs Pract; 2024 Apr; 30(2):e13243. PubMed ID: 38351900
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Impact of Commission on cancer Accreditation on cancer Survival: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis.
    Ahmed A; Whittington J; Shafaee Z
    Ann Surg Oncol; 2024 Apr; 31(4):2286-2294. PubMed ID: 38093167
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic value of circulating tumor cells associated with white blood cells in solid cancer: a systematic review and meta-analysis of 1471 patients with solid tumors.
    Ju M; Gao Z; Gu G; Huang H; Sun A; Zheng C; Li H; Zhang Y; Li K
    BMC Cancer; 2023 Dec; 23(1):1224. PubMed ID: 38087278
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cuproptosis-related molecular patterns and gene (ATP7A) in hepatocellular carcinoma and their relationships with tumor immune microenvironment and clinical features.
    Li S; Weng J; Xiao C; Lu J; Cao W; Song F; He Z; Zhang P; Zhu Z; Xu J
    Cancer Rep (Hoboken); 2023 Dec; 6(12):e1904. PubMed ID: 37885090
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. hsa_circ_0129047 Upregulates LYVE1 to Inhibit Hepatocellular Carcinoma Progression by Sponging miR-492.
    Feng Z; Wu J
    Dis Markers; 2023; 2023():6978234. PubMed ID: 37810197
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A nationwide study on the current treatment status and natural prognosis of hepatocellular carcinoma in elderly.
    Yoo JJ; Lee J; Choi GH; Lee MW; Park DA
    Sci Rep; 2023 Sep; 13(1):14584. PubMed ID: 37666940
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. treatment and outcomes of immune checkpoint inhibitors-associated colitis/diarrhea: A systematic review and meta-analysis.
    Ding M; Zhang X; Wang J; Gao F; Zheng X; Yuan J; Qi X
    Dig Liver Dis; 2023 Dec; 55(12):1621-1631. PubMed ID: 36894390
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Sustained viral response and relapse after discontinuation of oral antiviral drugs in HBeAg-positive patients with chronic hepatitis B infection.
    Sun F; Li Z; Hu L; Deng W; Jiang T; Wang S; Bi X; Lu H; Yang L; Lin Y; Zeng Z; Shen G; Liu R; Chang M; Wu S; Gao Y; Hao H; Xu M; Chen X; Zhang L; Lu Y; Dong J; Xie Y; Li M
    Front Immunol; 2022; 13():1082091. PubMed ID: 36505492
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Combination therapy of sorafenib and drug-eluting bead transarterial chemoembolization for advanced hepatocellular carcinoma with and without hepatic arteriovenous shunt.
    Chen PK; Chiu SH; Tsai MT; Chang KH; Chang WC; Lin HH; Lo CH; Huang GS; Chang PY
    J Chin Med Assoc; 2022 Apr; 85(4):491-499. PubMed ID: 35152226
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical effects and safety of different transarterial chemoembolization methods for bridging and palliative treatments in hepatocellular carcinoma.
    Mohr I; Vogeler M; Pfeiffenberger J; Sprengel SD; Klauss M; Radeleff B; Teufel A; Chang DH; Springfeld C; Longerich T; Merle U; Mehrabi A; Weiss KH; Mieth M
    J Cancer Res Clin Oncol; 2022 Nov; 148(11):3163-3174. PubMed ID: 35076764
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Which surgical strategy for colorectal cancer with synchronous hepatic metastases provides the best outcome? A comparison between primary first, liver first and simultaneous approach.
    Carbone F; Chee Y; Rasheed S; Cunningham D; Bhogal RH; Jiao L; Tekkis P; Kontovounisios C
    Updates Surg; 2022 Apr; 74(2):451-465. PubMed ID: 35040077
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Predictors of survival rate in patients with pancreatic cancer: A multi-center analytical study in Iran.
    Bahardoust M; Abyazi MA; Emami SA; Ghadimi P; Khodabandeh M; Mahmoudi F; Hosseinzadeh R; Heiat M; Agah S
    Cancer Rep (Hoboken); 2022 Aug; 5(8):e1547. PubMed ID: 34494396
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Four types of tumor progression after microwave ablation of single hepatocellular carcinoma of ≤5 cm: incidence, risk factors and clinical significance.
    Huang Z; Guo Z; Ni J; Zuo M; Zhang T; Ma R; An C; Huang J
    Int J Hyperthermia; 2021; 38(1):1164-1173. PubMed ID: 34376111
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Yttrium-90 Radioembolization for the treatment of Solitary, Unresectable HCC: The LEGACY Study.
    Salem R; Johnson GE; Kim E; Riaz A; Bishay V; Boucher E; Fowers K; Lewandowski R; Padia SA
    Hepatology; 2021 Nov; 74(5):2342-2352. PubMed ID: 33739462
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Systematic review and meta-analysis of randomized controlled trials on the effects of obeticholic acid on the blood lipid profile: Insights into liver disorders and liver cancer.
    Guan L; Miao P
    Eur J Pharmacol; 2020 Dec; 889():173616. PubMed ID: 33035521
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Fibroscan liver stiffness after anti-viral treatment for hepatitis C is independently associated with adverse outcomes.
    Vutien P; Kim NJ; Moon AM; Pearson M; Su F; Berry K; Gelman H; Ioannou GN
    Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1717-1727. PubMed ID: 32951216
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Microwave ablation versus radiofrequency ablation for perivascular hepatocellular carcinoma: a propensity score analysis.
    Feng Y; Wang L; Lv H; Shi T; Xu C; Zheng H; Qi J; Zhao X; Li J; Gao Y; Qin C; Zhu Q
    HPB (Oxford); 2021 Apr; 23(4):512-519. PubMed ID: 32839089
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma.
    Viganò L; Lleo A; Muglia R; Gennaro N; Samà L; Colapietro F; Roncalli M; Aghemo A; Chiti A; Di Tommaso L; Solbiati L; Colombo M; Torzilli G
    Updates Surg; 2020 Jun; 72(2):413-421. PubMed ID: 32323164
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Applicability of scoring systems predicting outcome of transarterial chemoembolization for hepatocellular carcinoma.
    Vogeler M; Mohr I; Pfeiffenberger J; Sprengel SD; Klauss M; Teufel A; Chang DH; Springfeld C; Longerich T; Merle U; Mehrabi A; Weiss KH; Mieth M
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):1033-1050. PubMed ID: 32107625
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Salvage treatment for recurrences after first resection of colorectal liver metastases: the impact of histopathological growth patterns.
    Nierop PMH; Galjart B; Höppener DJ; van der Stok EP; Coebergh van den Braak RRJ; Vermeulen PB; Grünhagen DJ; Verhoef C
    Clin Exp Metastasis; 2019 Apr; 36(2):109-118. PubMed ID: 30843120
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.